During the past decade, Border Medical Oncology conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 22 clinical trials were completed, i.e. on average, 36.1% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 10 clinical trials were completed. i.e. 34.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Border Medical Oncology" #1 sponsor was "Celgene" with 8 trials, followed by "BeiGene" with 5 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 4 trials sponsored, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Border Medical Oncology" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "Cancer Trials Ireland" with 3 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Border Medical Oncology" are "Prostate Cancer" (6 trials), "Breast Cancer" (5 trials), "Multiple Myeloma" (5 trials), "Melanoma" (3 trials) and "Non-Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Border Medical Oncology" in a lesser frequency.

Most popular intervention types in "Border Medical Oncology" are "Drug" (90 trials), "Other" (6 trials), "Biological" (5 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Capecitabine" (6 trials), "Carboplatin" (5 trials), "Gemcitabine" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Border Medical Oncology" are 76 trials for "All" genders, 11 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Border Medical Oncology". undefined are not yet recruiting, 25 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in Border Medical Oncology, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Border Medical Oncology, 15 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Border Medical Oncology has several departments that took part in Clinical trials: "Border Medical Oncology" - 9 trials